Abstract :
Dermatological issues pose a frequent challenge for small clinical practitioners, presenting a spectrum of conditions encompassing otitis, pyoderma, anal sac problems, flea allergy, and atopic dermatitis (AD). Atopic Dermatitis (AD) is a chronic and recurring skin condition characterized by distributed skin lesions. In recent decades, researchers have shown a keen interest in AD due to its increased prevalence in developed countries. While various treatment strategies, including biological and immune modulators, are available for AD, each has certain limitations. Researchers have exhibited a significant interest in managing AD with herbal medicines. The use of herbal drugs for AD could potentially eliminate local and systemic adverse effects associated with long-term corticosteroid use, as well as reduce the high cost of therapy with biological drugs. This review discusses traditional East Asian herbal medicines as well as scientific data related to newer herbal extracts or compositions for the treatment of AD. The paper also delves into in vivo animal models and in vitro cell cultures that have been investigated with herbal medicines to establish a potential role in the treatment of AD. In conclusion, herbal medicines could serve as a better and safer complementary and alternative treatment option for AD.
Keywords :
AD, Atopic dermatitis, curcuma longa, dermatology, DNCB, Dog, Terminalia chebula.References :
- Abood, W. N., Fahmi, I., Abdulla, M. A., and Ismail, S. (2014). Immunomodulatory effect of an isolated fraction from Tinospora crispa on the intracellular expression of INF-γ, IL-6, and IL-8. BMC complementary and alternative medicine, 14, 1-12.
- Ambily, V. R., Usha, N. P., Ajithkumar, S., Deepa, C., David, P. V., Aravindakshan, T. V., … & Krishna, B. D. (2023). Occurrence of allergic dermatitis in dogs with special reference to canine Atopic Dermatitis in Kerala.
- Andoh, T., Honma, Y., Kawaharada, S., Al-Akeel, A., Nojima, H., and Kuraishi, Y. (2003). Inhibitory effect of the repeated treatment with Unsei-in on substance P-induced itch-associated responses through the downregulation of the expression of NK1 tachykinin receptor in mice. Biological and Pharmaceutical Bulletin, 26(6), 896-898
- Asmita, N., Niddhi, A., Rajora, V. S., Meena, M., Singh, J. L., and Das, A. K. (2015). Prevalence of canine dermatoses in and around Pantnagar Uttarakhand, India. International Journal of Basic and Applied Agricultural Research, 13(2), 218-221.
- Aziz, S. J., and Zeman-Pocrnich, C. E. (2022). Tissue processing. Immunohistochemistry and Immunocytochemistry: Methods and Protocols, 47-63.
- Bachmann, M. F., Zeltins, A., Kalnins, G., Balke, I., Fischer, N., Rostaher, A., and Favrot, C. (2018). Vaccination against IL-31 for the treatment of Atopic Dermatitis in dogs. Journal of Allergy and Clinical Immunology, 142(1), 279-281.
- Bag, A., Kumar Bhattacharyya, S., Kumar Pal, N., and Ranjan Chattopadhyay, R. (2013). Anti-inflammatory, anti-lipid peroxidative, antioxidant, and membrane stabilizing activities of hydroalcoholic extract of Terminalia chebula Pharmaceutical biology, 51(12), 1515-1520.
- Benjamin, M. M. (2001). Outline of Clinical Veterinary Pathology. USA: Colorado State University.
- Bernard, F. X., Morel, F., Camus, M., Pedretti, N., Barrault, C., Garnier, J., and Lecron, J. C. (2012). Keratinocytes under fire of proinflammatory cytokines: bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. Journal of Allergy, 2012.
- Bhagya, B. K., Kamran, C. A., and Veeregowda, P. R. B. (2021). Dermatological diseases in pugs with special reference to canine atopic dermatitis.
- Bingham, E., Cohrssen, B., and Powell, C. H. (2001). Patty’s Toxicology. Volume 1: Toxicology issues, inorganic particulates, dust, products of biological origin and pathogens (No. Ed. 5). John Wiley and Sons.
- Bizikova, P., Santoro, D., Marsella, R., Nuttall, T., Eisenschenk, M. N., and Pucheu‐Haston, C. M. (2015). Clinical and histological manifestations of canine Atopic Dermatitis. Veterinary Dermatology, 26(2), 79-e24.
- Bönisch, C., Irmler, M., Brachthäuser, L., Neff, F., Bamberger, M. T., Marschall, S., and Beckers, J. (2016). Dexamethasone treatment alters insulin, leptin, and adiponectin levels in male mice as observed in DIO but does not lead to alterations of metabolic phenotypes in the offspring. Mammalian Genome, 27, 17-28.
- Bonneau, S., Skowronski, V., Sanquer, A., Maynard, L., and Eun, H. M. (2009). Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea‐allergy Dermatitis in dogs. Australian Veterinary Journal, 87(7), 287-291.
- Brar, R. K., Dhaliwal, P. S., Kumar, A., Chhabra, S., and Uppal, S. K. (2017). Clinico-pathological studies on Atopic Dermatitis in dogs. Journal of Animal Research, 7(3), 507-513.
- Bulbul, M. R. H., Chowdhury, M. N. U., Naima, T. A., Sami, S. A., Imtiaj, M. S., Huda, N., and Uddin, M. G. (2022). A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Heliyon, 8(8).
- Cardiff, R. D., Miller, C. H., & Munn, R. J. (2014). Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harbor Protocols, 2014(6), pdb-prot073411.
- Carroll, C. L., Balkrishnan, R., Feldman, S. R., Fleischer Jr, A. B., and Manuel, J. C. (2005). The burden of Atopic Dermatitis: impact on the patient, family, and society. Pediatric dermatology, 22(3), 192-199
- Chan, C. C., Liou, C. J., Xu, P. Y., Shen, J. J., Kuo, M. L., Len, W. B., and Huang, W. C. (2013). Effect of dehydroepiandrosterone on Atopic Dermatitis-like skin lesions induced by 1-chloro-2, 4-dinitrobenzene in mouse. Journal of Dermatological Science, 72(2), 149-157.
- Chan, L. S., Robinson, N., and Xu, L. (2001). Expression of interleukin-4 in the epidermis of transgenic mice results in pruritic inflammatory skin disease: an experimental animal model to study Atopic Dermatitis. Journal of Investigative Dermatology, 117(4), 977-983.
- Chandrasekaran, C. V., Sundarajan, K., Edwin, J. R., Gururaja, G. M., Mundkinajeddu, D., and Agarwal, A. (2013). Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacognosy Research, 5(2), 71.
- Chattopadhyay, R. R., and Bhattacharyya, S. K. (2007). Terminalia chebula: An update. Pharmacognosy Reviews, 1(1).
- Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B. S., and Chan, L. S. (2004). Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an Atopic Dermatitis model. Clinical & Experimental Immunology, 138(3), 375-387
- Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B. S., and Chan, L. S. (2004). Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an Atopic Dermatitis model. Clinical & Experimental Immunology, 138(3), 375-387.
- Cobb, M. A., Edwards, H. J., Jagger, T. D., Marshall, J., and Bowker, K. E. (2005). Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis. The Veterinary Journal, 169(2), 276-280.
- Coca, A. F., and Cooke, R. A. (1923). On the classification of the phenomena of hypersensitiveness. The journal of immunology, 8(3), 163-182.
- Couceiro, G. A., Ribeiro, S. M. M., Monteiro, M. M., Meneses, A. M. C., Sousa, S. K. S., and Coutinho, L. N. (2021). Prevalence of Canine Atopic Dermatitis at the Veterinary Hospital of the “Universidade Federal Rural da Amazônia” in Belém/Pará, Brazil. Pesquisa Veterinária Brasileira, 41.
- Cronin, J. R. (2003). Curcumin: Old spice is a new medicine. Alternative & complementary therapies, 9(1), 34-38.
- Cruikshank, R., Duguid, J. P. and R. H. A. Swain., (1965). Medical Microbiology, 1lth edn.Edinburgh: Livingstone. 851-852.
- Cumberbatch M Toxicologist 78 (1-S): 327 (2004)
- Cumberbatch, M., Clelland, K., Dearman, R. J., and Kimber, I. (2005). Impact of cutaneous IL-10 on resident epidermal Langerhans’ cells and the development of polarized immune responses. Journal of Immunology (Baltimore, Md.: 1950), 175(1), 43–50. https://doi.org/10.4049/jimmunol.175.1.43
- Eichenseer, M., Johansen, C., and Mueller, R. S. (2013). Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomized, controlled, double‐blinded trial. Veterinary Record, 173(17), 423-423.
- Favrot, C., Steffan, J., Seewald, W., and Picco, F. (2010). A prospective study on the clinical features of chronic canine Atopic Dermatitis and its diagnosis. Veterinary Dermatology, 21(1), 23-31.
- Feinstein, R., and Waggie, K. S. (2003). Postmortem procedures. Handbook of Laboratory Animal Science. Vol 1. Selection and handling of animals in biomedical research.
- Ferrer, L., Alberola, J., Queralt, M., Brazis, P., Rabanal, R., Llenas, J., and Puigdemont, A. (1999). Clinical anti‐inflammatory efficacy of arofylline, a new selective phosphodiesterase‐4 inhibitor, in dogs with atopic dermatitis. Veterinary Record, 145(7), 191-194.
- Furue, M., Terao, H., Rikihisa, W., Urabe, K., Kinukawa, N., Nose, Y., and Koga, T. (2003). Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. British Journal of Dermatology, 148(1), 128-133.
- Gortel, K. (2018). An embarrassment of riches: an update on the symptomatic treatment of Canine Atopic Dermatitis. The Canadian Veterinary Journal, 59(9), 1013
- Grewe, M., Gyufko, K., Schöpf, E., and Krutmann, J. (1994). Lesional expression of interferon-γ in atopic eczema. The Lancet, 343(8888), 25-26.
- Gross, T. L., Walder, E., and Ihrke, P. (1997). Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs. Veterinary Dermatology, 8(2), 127-131.
- Guaguère, E., Lasvergeres, F., and Arfi, L. (1996). Efficacy of oral methylprednisolone in the symptomatic treatment of Allergic Dermatitis of dogs.
- Gupta, P. C. (2012). Biological and pharmacological properties of Terminalia chebula (Haritaki)-An overview. International Journal Pharmacology Pharmaceutical Sciences, 4(3), 62-68
- Hakanen, E., Lehtimäki, J., Salmela, E., Tiira, K., Anturaniemi, J., Hielm-Björkman, A., and Lohi, H. (2018). Urban environment predisposes dogs and their owners to allergic symptoms. Scientific reports, 8(1), 1585.
- Haritha, G. S., Ramesh, P., Manoj Kumar, K., Srilatha, B., and Prakash Kumar, B. (2022). Study on prevalence of certain dermatological conditions in canines in Garividi region of Andhra Pradesh.
- Harvey, N. D., Shaw, S. C., Craigon, P. J., Blott, S. C., and England, G. C. (2019). Environmental risk factors for Canine Atopic Dermatitis: a retrospective large‐scale study in Labrador and golden retrievers. Veterinary Dermatology, 30(5), 396-e119.
- Hensel, P., Santoro, D., Favrot, C., Hill, P., and Griffin, C. (2015). Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Veterinary Research, 11(1), 1-13.
- Hillier, A. and Griffin, C. E. (2001) The ACVd task force on canine atopic dermatitis (i): incidence and prevalence. Veterinary Immunology and Immunopathology 81, 147-151
- Hwang, D. H., Koh, P. O., Kang, C., and Kim, E. (2021). Rosa davurica Pall. improves DNCB-induced Atopic Dermatitis in mice and regulates TNF-Alpa/IFN-gamma-induced skin inflammatory responses in HaCaT cells. Phytomedicine, 91, 153708.
- Jami, M. S. I., Sultana, Z., Ali, M. E., Begum, M. M., and Haque, M. M. (2014). Evaluation of analgesic and anti-inflammatory activities on ethanolic extract of Terminalia chebula fruits in experimental animal models. American Journal of Plant Sciences, 2014.
- Jankovic, D., and Feng, C. G. (2015). CD4+ T cell differentiation in infection: amendments to the Th1/Th2 axiom. Frontiers in Immunology, 6, 144703.
- Jantawong, C., Priprem, A., Intuyod, K., Pairojkul, C., Pinlaor, P., Waraasawapati, S., Mongkon, I., Chamgramol, Y. and Pinlaor, S. (2021). Curcumin-loaded nano complexes: Acute and chronic toxicity studies in mice and hamsters. Toxicology reports, 8, pp.1346-1357.
- Jensen, J. M., Pfeiffer, S., Witt, M., Bräutigam, M., Neumann, C., Weichenthal, M., and Proksch, E. (2009). Different effects of pimecrolimus and betamethasone on the skin barrier in patients with Atopic Dermatitis. Journal of Allergy and Clinical Immunology, 124(3), R19-R28
- Jewell, C., Heylings, J., Clowes, H. M., and Williams, F. M. (2000). Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro. Archives of Toxicology, 74(7), 356–365. https://doi.org/10.1007/s002040000123
- Jo, I. J. (2022). Inhibitory activity of Terminalia chebula extract against TNF-α/IFN-γ-induced chemokine increase on human keratinocyte, HaCaT cells. The Korea Journal of Herbology, 37(3), 41-47.
- Jyothi, J., Kumar, K. S., Nagaraj, P., Reddy, K. C., and Rao, T. M. (2013). Diagnostic and therapeutic management of Canine Atopic Dermatitis. Intas Polivet, 14(2), 245-252.
- Ka, D., Marignac, G., Desquilbet, L., Freyburger, L., Hubert, B., Garelik, D., and Perrot, S. (2014). Association between passive smoking and Atopic Dermatitis in dogs. Food and Chemical Toxicology, 66, 329-333.
- Kerschenlohr, K., Decard, S., Przybilla, B., and Wollenberg, A. (2003). Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic Atopic Dermatitis. Journal of allergy and clinical immunology, 111(4), 869-874.
- Kim, H. J., Song, H. K., Park, S. H., Jang, S., Park, K. S., Song, K. H., Lee, S. K. and Kim, T. (2022). Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-ĸB signaling in vitro. Phytomedicine, 104, 154318.
- Kim, H., Kim, J. R., Kang, H., Choi, J., Yang, H., Lee, P., and Lee, K. W. (2014). 7, 8, 4′-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PloS one, 9(8), e104938.
- Kim, J., Park, S., Jeon, B. S., Jang, W. S., Lee, S. J., Son, Y., and Lee, S. S. (2016). Therapeutic effect of topical application of curcumin during treatment of radiation burns in a mini-pig model. Journal of Veterinary Science, 17(4), 435-444.
- Kim, S. J. (2018). The Inhibitory Effect of Gooseberry on DNCB-induced Atopic Dermatitis in vivo and in vitro. Biomedical Science Letters, 24(4), 349-356.
- Kimura, T., and Doi, K. (1999). Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids. Toxicologic Pathology, 27(5), 528-535.
- Ku, J. M., Hong, S. H., Kim, H. I., Seo, H. S., Shin, Y. C., and Ko, S. G. (2017). Effects of Angelicae dahuricae Radix on 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model. BMC complementary and alternative medicine, 17, 1-8.
- Labban, L. (2014). Medicinal and pharmacological properties of Turmeric (Curcuma longa): A review. Int J Pharm Biomed Sci, 5(1), 17-23
- Langan, S.M.; Irvine, A.D.; Weidinger, S. Atopic dermatitis. Lancet Lond. Engl. 2020, 396, 345–360.
- Lee, H. S., Choi, E. J., Lee, K. S., Kim, H. R., Na, B. R., Kwon, M. S., and Jun, C. D. (2016). Oral administration of p-hydroxycinnamic acid attenuates atopic dermatitis by downregulating Th1 and Th2 cytokine production and keratinocyte activation. PLoS One, 11(3), e0150952.
- Lee, Y. S., Ryu, H. W., Yang, W. K., Park, M. H., Park, Y. C., Kim, D. Y., and Kim, S. H. (2021). A combination of Olea europaea leaf extract and Spirodela polyrhiza extract alleviates atopic dermatitis by modulating immune balance and skin barrier function in a 1-chloro-2, 4-dinitrobenzene-induced murine model. Phytomedicine, 82, 153407
- Luger, T., Amagai, M., Dreno, B., Dagnelie, M. A., Liao, W., Kabashima, K., and Schmuth, M. (2021). Atopic Dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. Journal of Dermatological Science, 102(3), 142-157.
- Lund, E. M., Armstrong, P. J., Kirk, C. A., Kolar, L. M. and Klausner, J. s. (1999) Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. Journal of the American Veterinary Medical Association 214, 1336-1341
- Macedo, A. G., Krug, A. L. O., Souza, L. M., Martuscelli, A. M., Constantino, P. B., Zago, A. S., and Amaral, S. L. (2016). Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone. Steroids, 107, 30-36.
- Majewska, A., Gajewska, M., Dembele, K., Maciejewski, H., Prostek, A., and Jank, M. (2016). Lymphocytic, cytokine, and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis. BMC Veterinary Research, 12(1), 1-14.
- Marsella, R., Nicklin, C. F., and Melloy, C. (2002). The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled, cross‐over clinical trial. Veterinary dermatology, 13(3), 131-139.
- Matsuda, H., Watanabe, N., Geba, G. P., Sperl, J., Tsudzuki, M., Hiroi, J., and Ra, C. (1997). Development of Atopic Dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. International immunology, 9(3), 461-466.
- Matsuoka, H., Maki, N., Yoshida, S., Arai, M., Wang, J., Oikawa, Y., and Ishii, A. (2003). A mouse model of atopic eczema/dermatitis syndrome by repeated application of a crude extract of house‐dust mite Dermatophagoides farinae. Allergy, 58(2), 139-145.
- Meng, Y., Liu, Z., Zhai, C., Di, T., Zhang, L., Zhang, L., and Li, P. (2019). Paeonol inhibits the development of 1‑chloro‑2, 4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice. Molecular Medicine Reports, 19(4), 3217-3229.
- Meury, S., Molitor, V., Doherr, M. G., Roosje, P., Leeb, T., Hobi, S., and Favrot, C. (2011). Role of the environment in the development of canine atopic dermatitis in Labrador and golden retrievers. Veterinary Dermatology, 22(4), 327-334.
- Mujumdar, A. M., Naik, D. G., Dandge, C. N., and Puntambekar, H. M. (2000). Anti-inflammatory activity of Curcuma amada in albino rats. Indian Journal of Pharmacology, 32(6), 375-377.
- Nakajima, S., Tie, D., Nomura, T., and Kabashima, K. (2021). Novel pathogenesis of Atopic Dermatitis from the view of cytokines in mice and humans. Cytokine, 148, 155664.
- Nam, D. Y., Lee, J. M., Heo, J. C. and Lee, S. H. (2011). Mitigation of 2, 4-dinitrofluorobenzene-induced atopic dermatitis-related symptoms by Terminalia chebula International Journal of Molecular Medicine, 28(6), 1013-1018.
- National Center for Biotechnology Information (2024). PubChem Annotation Record for, 1-CHLORO-2,4-DINITROBENZENE, Source: Hazardous Substances Data Bank (HSDB). Retrieved March 11, 2024 from https://pubchem.ncbi.nlm.nih.gov.
- National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 6, 1-Chloro-2,4-dinitrobenzene. Retrieved March 11, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/1-Chloro-2_4-dinitrobenzene.
- Niranjan, A., and Prakash, D. (2008). Chemical constituents and biological activities of turmeric (Curcuma longa)-a review. Journal of Food Science and Technology, 45(2), 109
- Nødtvedt, A., Bergvall, K., Sallander, M., Egenvall, A., Emanuelson, U., and Hedhammar, Å. (2007). A case-control study of risk factors for canine atopic dermatitis among boxer, bullterrier, and West Highland white terrier dogs in Sweden. Veterinary Dermatology, 18(5), 309-315.
- Nødtvedt, A., Egenvall, A., Bergval, K., and Hedhammar, Å. (2006). Incidence of and risk factors for atopic dermatitis in a Swedish population of insured dogs. Veterinary Record, 159(8), 241-246
- Nomura, T., Honda, T., and Kabashima, K. (2018). Multipolarity of cytokine axes in the pathogenesis of Atopic Dermatitis in terms of age, race, species, disease stage and biomarkers. International immunology, 30(9), 419-428.
- Novak, N., Bieber, T., and Leung, D. Y. (2003). Immune mechanisms leading to Atopic Dermatitis. Journal of Allergy and Clinical Immunology, 112(6), S128-S139.
- Nuttall, T. (2013). The genomics revolution: will canine atopic dermatitis be predictable and preventable? Veterinary Dermatology, 24(1), 10-e4.
- Nuttall, T. J., McEwan, N. A., Bensignor, E., Cornegliani, L., Löwenstein, C., and Reme, C. A. (2012). Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine Atopic Dermatitis. Veterinary Dermatology, 23(1), 4-e2.
- Nuttall, T., Uri, M., and Halliwell, R. (2013). Canine Atopic Dermatitis–what have we learned? Veterinary Record, 172(8), 201-207.
- Olivry, T. (2004). Pathogenesis of Canine Atopic Dermatitis: 2004 hypothesis. Veterinary Dermatology, 15, 1-1.
- Olivry, T., Dean, G. A., Tompkins, M. B., Dow, J. L., and Moore, P. F. (1999). Toward a canine model of Atopic Dermatitis: amplification of cytokine‐gene transcripts in the skin of atopic dogs. Experimental Dermatology, 8(3), 204-211.
- Ong, P. Y., and Leung, D. M. (2006). Immune dysregulation in Atopic Dermatitis. Current allergy and asthma reports, 6(5), 384-389.
- Outerbridge, C. A., and Jordan, T. J. (2021). Current knowledge on Canine Atopic Dermatitis: Pathogenesis and treatment. Advances in small animal care, 2, 101-115.
- Panunto, W., Jaijoy, K., Lerdvuthisopon, N., Lertprasertsuke, N., Jiruntanat, N., Soonthornchareonnon, N., and Sireeratawong, S. (2010). Acute and chronic toxicity studies of the water extract from dried fruits of Terminalia chebula in rats. International Journal of Applied Research in Natural Products, 3(4), 36-43.
- Paradis, M., Scott, D. W., and Giroux, D. (1991). Further investigations on the use of nonsteroidal and steroidal anti-inflammatory agents in the management of canine pruritus.
- Park, B. K., Park, Y. C., Jung, I. C., Kim, S. H., Choi, J. J., Do, M., and Jin, M. (2015). Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of Atopic Dermatitis. Journal of Ethnopharmacology, 165, 54-60.
- Peng, W., and Novak, N. (2015). Pathogenesis of Atopic Dermatitis. Clinical & Experimental Allergy, 45(3), 566-574.
- Pucheu‐Haston, C. M., Shuster, D., Olivry, T., Brianceau, P., Lockwood, P., McClanahan, T., and Hammerberg, B. (2006). A canine model of cutaneous late‐phase reactions: prednisolone inhibition of cellular and cytokine responses. Immunology, 117(2), 177-187
- Puigdemont, A., Brazís, P., Ordeix, L., Dalmau, A., Fuertes, E., Olivar, A., and Ravera, I. (2013). Efficacy of a new topical cyclosporine A formulation in the treatment of Atopic Dermatitis in dogs. The Veterinary Journal, 197(2), 280-285.
- RAI, A. K., and Joshi, R. (2009). Evaluation of antimicrobial properties of fruit extracts of Terminalia chebula against dental caries pathogens.
- Rangsriwong, P., Rangkadilok, N., Satayavivad, J., Goto, M., and Shotipruk, A. (2009). Subcritical water extraction of polyphenolic compounds from Terminalia chebula Retz. fruits. Separation and Purification Technology, 66(1), 51-56.
- Ravindranath, V., and Chandrasekhara, N. (1981). In-vitro studies on the intestinal absorption of curcumin in rats. Toxicology, 20(2-3), 251-257
- Roosje, P. J., Dean, G. A., Willemse, T., MG Rutten, V. P., and Thepen, T. (2002). Interleukin 4-producing CD4+ T cells in the skin of cats with allergic dermatitis. Veterinary pathology, 39(2), 228-233.
- Rostaher, A., Dolf, G., Fischer, N. M., Silaghi, C., Akdis, C., Zwickl, L., and Favrot, C. (2020). Atopic dermatitis in a cohort of West Highland white terriers in Switzerland. Part II: Estimates of early life factors and heritability. Veterinary Dermatology, 31(4), 276-e66
- Rubab, I., and Ali, S. (2016). Dried fruit extract of Terminalia chebula modulates the immune response in mice. Food and Agricultural Immunology, 27(1), 1-22.
- Saeedi, M., Morteza‐Semnani, K., and Ghoreishi, M. R. (2003). The treatment of Atopic Dermatitis with licorice Journal of Dermatological Treatment, 14(3), 153-157.
- Sahne, F., Mohammadi, M., Najafpour, G. D., and Moghadamnia, A. A. (2016). Extraction of bioactive compound curcumin from turmeric (Curcuma longa) via different routes: A comparative study. Pakistan Journal of Biotechnology, 13(3), 173-180.
- Saridomichelakis, M. N., and Olivry, T. (2016). An update on the treatment of Canine Atopic Dermatitis. The Veterinary Journal, 207, 29-37
- Sarma, K., Mondal, D. B., Saravanan, M., Kumar, M., and Vijaykumar, H. (2013). Incidence of dermatological disorders and its therapeutic management in canines. Intas Polivet, 14(2), 186-192.
- Satyavati, G. V., Raina, M. K., & Sharma, M. (1987). Medicinal plants of India (Vol. 2). Indian Council of Medical Research.
- Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004). Interferon-γ: an overview of signals, mechanisms and functions. Journal of Leucocyte Biology, 75(2), 163-189
- Scott, D. W. (2001). Skin immune system and allergic skin disease. Small Animal Dermatology, 543-666
- Sekine, R., Satoh, T., Takaoka, A., Saeki, K., & Yokozeki, H. (2012). Anti-pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen‐induced scratching behavior. Experimental dermatology, 21(3), 201-204.
- Seyfried, J., & Willner, U. (2007). Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway. Biochemical and biophysical research communications, 359(3), 759–764. https://doi.org/10.1016/j.bbrc.2007.05.176
- Sharma, R., Hussain, K., Chhibber, S., Kumar, M., and Sharma, N. (2015). Allergic dermatitis occurrence pattern in canine of Jammu region, India. Journal of Animal Research, 5(3), 533-537.
- Sharma, S., Sethi, G. S., and Naura, A. S. (2020). Curcumin ameliorates ovalbumin-induced Atopic Dermatitis and blocks the progression of atopic march in mice. Inflammation, 43, 358-369.
- Shaw, S. C., Wood, J. L., Freeman, J., Littlewood, J. D., and Hannant, D. (2004). Estimation of heritability of Atopic Dermatitis in Labrador and Golden Retrievers. American journal of veterinary research, 65(7), 1014-1020.
- Shin, H. S., See, H. J., Jung, S. Y., Choi, D. W., Kwon, D. A., Bae, M. J., and Shon, D. H. (2015). Turmeric (Curcuma longa) attenuates food allergy symptoms by regulating type 1/type 2 helper T cells (Th1/Th2) balance in a mouse model of food allergy. Journal of Ethnopharmacology, 175, 21-29.
- Singh, D., Singh, D., Choi, S. M., Zo, S. M., Painuli, R. M., Kwon, S. W., and Han, S. S. (2014). Effect of extracts of Terminalia chebula on proliferation of keratinocytes and fibroblasts cells: an alternative approach for wound healing. Evidence-Based Complementary and Alternative Medicine, 2014.
- Singh, N. S., Das, G., Gonmei, C., Lalmuanpuii, R., and Shah, N. (2022). Incidence of Canine Atopic Dermatitis (CAD) in Mizoram. Journal of Animal Research, 12(1), 111-116.
- Sorg, D. A., and Buckner, B. (1964). A simple method of obtaining venous blood from small laboratory animals. Proceedings of the Society for Experimental Biology and Medicine, 115(4), 1131-1132.
- Souza, C. P., Rosychuk, R. A., Contreras, E. T., Schissler, J. R., and Simpson, A. C. (2018). A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the Western USA. Veterinary Dermatology, 29(6), 489-e164
- Spergel, J. M., and Paller, A. S. (2003). Atopic Dermatitis and the atopic march. Journal of Allergy and Clinical Immunology, 112(6), S118-S127.
- Sun, J., Ramnath, R. D., and Bhatia, M. (2007). Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils. American Journal of Physiology-Cell Physiology, 293(2), C696-C704.
- Suryawati, N., Wardhana, M., Bakta, I. M., and Jawi, M. (2022). Moisturizing Nanoemulgel of Turmeric (Curcuma longa) Rhizome Extract Ameliorates Atopic Dermatitis-like Skin Lesions in Mice Model through Thymic Stromal Lymphopoietin, Interleukin-13, and Interleukin-17. Biomolecular and Health Science Journal, 5(2), 81-87.
- Suryawati, N., Wardhana, M., Bakta, I. M., and Jawi, M. (2022). Moisturizing Nanoemulgel of Turmeric (Curcuma longa) Rhizome Extract Ameliorates Atopic Dermatitis-like Skin Lesions in Mice Model through Thymic Stromal Lymphopoietin, Interleukin-13, and Interleukin-17. Biomolecular and Health Science Journal, 5(2), 81-87.
- Suto, H., Matsuda, H., Mitsuishi, K., Hira, K., Uchida, T., Unno, T., and Ra, C. (1999). NC/Nga mice: a mouse model for Atopic Dermatitis. International archives of allergy and immunology, 120(Suppl. 1), 70-75.
- Takamori, A., Nambu, A., Sato, K., Yamaguchi, S., Matsuda, K., Numata, T., and Nakae, S. (2018). IL-31 is crucial for the induction of pruritus, but not inflammation, in contact hypersensitivity. Scientific Reports, 8(1), 6639.
- Tarpataki, N., Pápa, K., Reiczigel, J., Vajdovich, P., and Vörös, K. (2006). Prevalence and features of canine atopic dermatitis in Hungary. Acta Veterinaria Hungarica, 54(3), 353-366.
- Thepen, T., Langeveld-Wildschut, E. G., Bihari, I. C., van Wichen, D. F., van Reijsen, F. C., Mudde, G. C., and Bruijnzeel-Koomen, C. A. (1996). Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. Journal of Allergy and Clinical Immunology, 97(3), 828-837.
- Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H. U., Graeve, T., and Akdis, C. A. (2000). T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. The Journal of Clinical Investigation, 106(1), 25-35.
- Uehara, M., Sugiura, H., and Sakurai, K. (2001). A trial of oolong tea in the management of recalcitrant Atopic Dermatitis. Archives of dermatology, 137(1), 42-43.
- Varughese, H. S., and Chitra, M. A. (2022). Prevalence of dermatological conditions in dogs in Chennai. Veterinary Practitioner, 23(1).
- Verma, R. K., Kumari, P., Maurya, R. K., Kumar, V., Verma, R. B., and Singh, R. K. (2018). Medicinal properties of turmeric (Curcuma longa L.): A review. International Journal Chem. Stud, 6(4), 1354-1357.
- Wang, X. (2020). Induction effect of DNCB on Atopic Dermatitis BALB/c mice and its mechanism. Journal of Jilin University (Medicine Edition), 439-443
- Wang, Y., Zhang, P., Zhang, J., and Hong, T. (2022). Inhibitory Effect of Bisdemethoxycurcumin on DNCB-Induced Atopic Dermatitis in Mice. Molecules, 28(1), 293.
- Wilhelm, s., Kovalik, M. and FAVRot, C. (2011) Breed-associated phenotypes in Canine Atopic Dermatitis. Veterinary Dermatology 22, 143-149
- Wilson, S. R., Batia, L. M., Beattie, K., Katibah, G. E., McClain, S. P., Pellegrino, M., and Bautista, D. M. (2013). The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell, 155(2), 285-295.
- Wise F, Sulzberger MG. In Year Book of Dermatology and Syphilology. 1933:38-9.
- Wood, S. H., Ollier, W. E., Nuttall, T., McEwan, N. A., and Carter, S. D. (2010). Despite identifying some shared gene associations with human Atopic Dermatitis the use of multiple dog breeds from various locations limits the detection of gene associations in Canine Atopic Dermatitis. Veterinary Immunology and Immunopathology, 138(3), 193-197.
- Xiong, X., Huang, C., Wang, F., Dong, J., Zhang, D., Jiang, J., … and Cheng, L. (2021). Qingxue jiedu formulation ameliorated DNFB-induced Atopic Dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways. Journal of Ethnopharmacology, 270, 113773.
- Yagi, R., Nagai, H., Iigo, Y., Akimoto, T., Arai, T., and Kubo, M. (2002). Development of atopic Dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. The Journal of Immunology, 168(4), 2020-2027.
- Yamanaka, K. I., and Mizutani, H. (2011). The role of cytokines/chemokines in the pathogenesis of Atopic Dermatitis. Pathogenesis and Management of Atopic Dermatitis, 41, 80-92.
- Yang, C. C., Hung, Y. L., Ko, W. C., Tsai, Y. J., Chang, J. F., Liang, C. W., and Hung, C. F. (2021). Effect of neferine on DNCB-induced Atopic Dermatitis in HaCaT cells and BALB/c mice. International Journal of Molecular Sciences, 22(15), 8237.
- Yousif, A. D., and Abu-Raghif, A. R. (2020). The effect of topical dapsone in comparison with tacrolimus on DNCB-induced Atopic Dermatitis in mice. International Journal of Research in Pharmaceutical Sciences, 11, 2050-2062.
- Zhang, E. Y., Chen, A. Y., and Zhu, B. T. (2009). Mechanism of dinitro chlorobenzene induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One, 4(11), e7703
- Zhang, R., Zhang, H., Shao, S., Shen, Y., Xiao, F., Sun, J., and Yan, M. (2022). Compound traditional Chinese medicine Dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in Atopic Dermatitis. Chinese Medicine, 17, 1-19.
- Zhao, H., Jiang, X., and Chu, W. (2020). Shifts in the gut microbiota of mice in response to dexamethasone administration. International Microbiology, 23, 565-573.